柔荣's profile不孕不育新进展(英文)PhotosBlogListsMore Tools Help

Blog


    6/22/2009

    Metformin reduces serum müllerian-inhibiting


    Richard Fleming, Ph.D.,a Lyndal Harborne, B.Med.,a David T. MacLaughlin, Ph.D.,b
    Daniel Ling,b Jane Norman, M.D.,a Naveed Sattar, M.R.C.Path.,a and David B. Seifer, M.D.c
    a University Department of Obstetrics and Gynaecology, Royal Infirmary, Glasgow, United Kingdom; b Paediatric Research
    Laboratory, Massachusetts General Hospital for Children and Harvard Medical School, Boston, Massachusetts; and c Department
    of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, University
    of Medicine and Dentistry of New Jersey—Robert Wood Johnson Medical School, New Brunswick, New Jersey
    Objective: Assessment of ovarian responses to metformin treatment in obese women with polycystic ovary
    syndrome (PCOS).
    Design: Prospective treatment with randomization to two doses of metformin.
    Setting: University teaching hospital.
    Patient(s): Obese women (n  82) with PCOS.
    Intervention(s): Markers of ovarian function were assessed after 4 and 8 months.
    Main Outcome Measure(s): Hormone (androgens and müllerian-inhibiting substance [MIS]) changes over time.
    Result(s): There was no difference in the reproductive hormone changes between the doses of metformin, and
    data were combined for further analyses. Significant responses to treatment were recorded for menstrual
    frequency and androstenedione (A) (reduction) within the first 4 months of treatment. However, suppression of
    the elevated circulating MIS concentrations required protracted treatment, because no change was observed in the
    first 4 months—only in the second 4-month assessment period.
    Conclusion(s): Metformin treatment of PCOS leads to rapid suppression of A and improved menstrual frequency.
    Suppression of MIS is a delayed response that may be secondary to the development of a cohort of follicles that
    underwent initial recruitment in an environment of reduced insulin stimulation. (Fertil Steril 2005;83:130–6. ©
    2005 by American Society for Reproductive Medicine.)
    Key Words: Müllerian-inhibiting substance, PCOS, metformin, ovarian follicles

    Comments

    Please wait...
    Sorry, the comment you entered is too long. Please shorten it.
    You didn't enter anything. Please try again.
    Sorry, we can't add your comment right now. Please try again later.
    To add a comment, you need permission from your parent. Ask for permission
    Your parent has turned off comments.
    Sorry, we can't delete your comment right now. Please try again later.
    You've exceeded the maximum number of comments that can be left in one day. Please try again in 24 hours.
    Your account has had the ability to leave comments disabled because our systems indicate that you may be spamming other users. If you believe that your account has been disabled in error please contact Windows Live support.
    Complete the security check below to finish leaving your comment.
    The characters you type in the security check must match the characters in the picture or audio.

    To add a comment, sign in with your Windows Live ID (if you use Hotmail, Messenger, or Xbox LIVE, you have a Windows Live ID). Sign in


    Don't have a Windows Live ID? Sign up

    Trackbacks

    The trackback URL for this entry is:
    http://lrrivf.spaces.live.com/blog/cns!C77791AAB4F59DF4!202.trak
    Weblogs that reference this entry
    • None